logo
logo

Clinchoice Raises $150 Mm Series E Round Financing, Further Strengthening Its Global Services Capabilities

Clinchoice Raises $150 Mm Series E Round Financing, Further Strengthening Its Global Services Capabilities

07/05/22, 9:20 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgphiladelphia
Money raised
$150 million
Round Type
series e
Recently, ClinChoice announced the successful completion of its $150 mm Series E round financing. The investment was led by Legend Capital, and co-invested by Taikang Life Insurance, Sherpa Healthcare Partners and existing shareholders, including Lilly Asia Ventures and Apricot Capital. Proceeds of the financing will be used to fund the Company's continued business expansion and innovative service offering worldwide.

Company Info

Company
Clin Choice
Location
philadelphia, pennsylvania, united states
Additional Info
ClinChoice is a global clinical CRO, providing high-quality Integrated One-stop Service Offerings for new bio-pharmaceutical and medical device clients worldwide. Our Service Offerings cover Clinical Operation, Project Management, Biostatistics, Data Management, Biostatistical Programming, Regulatory Affairs, Medical Affairs, Feasibility Research, HGRAC Submission, Clinical Safety Management, Site Management Organization, Nature Medicine/Traditional Chinese Medicine and Phase I Clinical Research, etc. Now, ClinChoice has over 3,000 employees worldwide covering most of drug development hotbeds in US, China, multiple countries in Europe and Southeast Asia. Since its inception, ClinChoice has completed multiple rounds of financing, with investments from renowned institutional investors including Goldman Sachs, Lilly Asia Ventures, and DFJ Dragon Fund.